Apolipoprotein-mediated pathways of lipid antigen presentation
- 1 October 2005
- journal article
- letter
- Published by Springer Nature in Nature
- Vol. 437 (7060) , 906-910
- https://doi.org/10.1038/nature04001
Abstract
Peptide antigens are presented to T cells by major histocompatibility complex (MHC) molecules, with endogenous peptides presented by MHC class I and exogenous peptides presented by MHC class II. In contrast to the MHC system, CD1 molecules bind lipid antigens that are presented at the antigen-presenting cell (APC) surface to lipid antigen-reactive T cells1. Because CD1 molecules survey endocytic compartments2, it is self-evident that they encounter antigens from extracellular sources. However, the mechanisms of exogenous lipid antigen delivery to CD1-antigen-loading compartments are not known. Serum apolipoproteins are mediators of extracellular lipid transport for metabolic needs3. Here we define the pathways mediating markedly efficient exogenous lipid antigen delivery by apolipoproteins to achieve T-cell activation. Apolipoprotein E binds lipid antigens and delivers them by receptor-mediated uptake into endosomal compartments containing CD1 in APCs. Apolipoprotein E mediates the presentation of serum-borne lipid antigens and can be secreted by APCs as a mechanism to survey the local environment to capture antigens or to transfer microbial lipids from infected cells to bystander APCs. Thus, the immune system has co-opted a component of lipid metabolism to develop immunological responses to lipid antigens.Keywords
This publication has 28 references indexed in Scilit:
- Mycobacterium tuberculosis pks12 Produces a Novel Polyketide Presented by CD1c to T CellsThe Journal of Experimental Medicine, 2004
- Quantitative and Qualitative Differences in Proatherogenic NKT Cells in Apolipoprotein E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- CD1: Antigen Presentation and T Cell FunctionAnnual Review of Immunology, 2004
- New insights into pathways for CD1-mediated antigen presentationCurrent Opinion in Immunology, 2004
- CD1d-dependent Activation of NKT Cells Aggravates AtherosclerosisThe Journal of Experimental Medicine, 2004
- Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasitesBlood, 2003
- Differential Metabolism of Human VLDL According to Content of ApoE and ApoC-IIIArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Glycolipid Antigen Processing for Presentation by CD1d MoleculesScience, 2001
- The Influence of Apolipoprotein E on the Interactions between Normal Human Very Low Density Lipoproteins and U937 Human Macrophages: Heterogeneity among PersonsVascular Medicine, 1996
- Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.Journal of Clinical Investigation, 1985